Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
Persistent bone pain that does not resolve with rest or standard treatment can signal an underlying metabolic bone disorder, including a rare inherited condition called hypophosphatasia (HPP), which impairs the enzyme needed to mineralize bone and teeth. Adults with HPP often report aching thighs and feet, stress fractures that heal slowly, early tooth loss, muscle weakness, and years of misdiagnosis as fibromyalgia, osteoporosis, or arthritis. A low serum alkaline phosphatase level is the key clue, and confirmation usually involves vitamin B6 testing, urine phosphoethanolamine, imaging, and genetic testing of the ALPL gene. Because untreated HPP can lead to repeated fractures, chronic pain, and mobility loss, timely evaluation matters, and several important red flags and testing details are explained below.
Lingering bone pain has many possible explanations, from vitamin D deficiency and overuse injury to rare enzyme disorders, so guessing rarely leads to the right next step. A free, instant, online symptom check can help you organize your symptoms, see which possibilities fit your pattern, and understand whether you should request specific lab work or urgent care now.
Last reviewed for medical accuracy: 08/18/2026
Why Bone Pain Lingers: Rare Hypophosphatasia & Urgent Next Steps
Persistent bone pain can be frustrating and disruptive. While common causes like arthritis, osteoporosis or overuse often come to mind first, there’s a rare genetic condition—hypophosphatasia—that can underlie lingering skeletal discomfort. Understanding this disorder, its warning signs and the right next steps can help you or a loved one get answers and relief sooner.
Hypophosphatasia (HPP) is an inherited disorder caused by mutations in the ALPL gene. This gene directs your body to produce an enzyme called tissue‐nonspecific alkaline phosphatase (TNSALP). When TNSALP levels are too low, bones and teeth can’t mineralize properly. As a result:
HPP can present at any age, from before birth through adulthood. Adult‐onset HPP often shows up as chronic bone or joint pain, muscle weakness and stress fractures that heal poorly.
Impaired Mineralization
• Low alkaline phosphatase allows pyrophosphate (PPi) to build up. PPi directly inhibits bone mineralization.
• Reduced mineral density makes bones more fragile and painful under normal stress.
Delayed or Nonunion Fractures
• Fractures may heal slowly or not at all, causing ongoing pain.
• The same microfractures can reoccur, perpetuating the pain cycle.
Muscle and Joint Strain
• Weaker bones alter your movement patterns, stressing muscles and joints.
• Over time, this compensation leads to tendonitis, bursitis or chronic joint pain.
Nerve Sensitization
• Persistent skeletal stress can sensitize pain receptors (central sensitization).
• Your nervous system remains “on alert,” amplifying ordinary aches into chronic pain.
Hypophosphatasia symptoms can overlap with other conditions. Consider HPP if you notice:
Because HPP is rare, it’s often misdiagnosed as:
A thorough evaluation usually includes:
Blood Tests
Genetic Testing
Imaging Studies
Functional Assessments
While there’s no cure, targeted therapies and supportive measures can reduce pain and improve function:
• Enzyme Replacement Therapy (ERT)
– Asfotase alfa: the first approved ERT for pediatric and adult HPP. It replaces missing TNSALP and promotes bone mineralization.
– Requires regular injections under specialist supervision.
• Pain Management
– Nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen for short-term relief.
– Avoid bisphosphonates – these common osteoporosis drugs can worsen HPP by further inhibiting bone turnover.
• Physical Therapy
– Strengthening exercises to support weak muscles and improve balance.
– Low-impact aerobic activities (walking, swimming) to reduce joint stress.
• Nutrition & Supplements
– Ensure adequate vitamin D and calcium, under your doctor’s guidance.
– Vitamin B6 levels should be monitored, as HPP leads to elevated B6 in blood.
• Orthopedic Care
– Stabilization of fractures, bracing for stress lines and surgical repair when necessary.
Managing chronic bone pain and maintaining quality of life involves:
Contact a healthcare professional right away if you experience:
Hypophosphatasia is a rare but important cause of persistent bone pain. Low alkaline phosphatase levels lead to poor bone mineralization, stress fractures and long-standing discomfort. Early recognition, accurate diagnosis and specialist-guided treatment can make a real difference. If you’ve battled unexplained bone pain or fractures, take the first step today:
Above all, never ignore persistent or severe pain. Speak to a doctor about anything that could be life threatening or serious. Your bones—and your future—are worth it.
(References)
* Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Dahir KM, Nunes ME. Hypophosphatasia. 1993. PMID: 20301329.
* Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, Aguiar CL, Akikusa JD, Akca UK, Almeida B, Appenzeller S, Balay-Dustrude E, Basaran O, Basiaga ML, Bilginer Y, Cabral DA, Capponi M, Donaldson N, Egeli BH, Fox EJ, Insalaco A, Iyer RS, Jansson AF, Kostik I, Kostik M, Kovalick LK, Kozu KT, Lapidus SK, Lee TC, Lenert A, Mahmood K, Marrani E, Mosad Mosa D, Muse I, Mushkin A, Nowicki KD, Nuruzzaman F, Onel K, Pardeo M, Pham TS, Potts L, Ramanan AV, Ravelli A, Rogers ND, Grim AW, Romano M, Rosenwasser N, Sato TS, Simonini G, Soep JB, Stern SM, Strauss T, Kohli AT, Theos AC, Tucker LB, Vogel LF, Yasin S, Wong SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO). Ann Rheum Dis. 2025 Sep;84(9):1458-1468. doi: 10.1016/j.ard.2024.11.006. Epub 2025 Jan 30. PMID: 39966038.
* Zhao Y, Oliver MS, Schnabel A, Wu EY, Wang Z, Marino A, Aguiar CL, Akikusa JD, Akca UK, Almeida B, Appenzeller S, Balay-Dustrude E, Basaran O, Basiaga ML, Bilginer Y, Cabral DA, Capponi M, Donaldson N, Egeli BH, Fox EJ, Insalaco A, Iyer RS, Jansson AF, Kostik I, Kostik M, Kovalick LK, Kozu KT, Lapidus SK, Lee TC, Lenert A, Mahmood K, Marrani E, Mosa DM, Muse I, Mushkin A, Nowicki KD, Nuruzzaman F, Onel K, Pardeo M, Pham TS, Potts L, Ramanan AV, Ravelli A, Rogers ND, Grim AW, Romano M, Rosenwasser N, Sato TS, Simonini G, Soep JB, Stern SM, Strauss T, Kohli AT, Theos AC, Tucker LB, Vogel LF, Yasin S, Wong SC, Bouchalova K, Hendry AM, Cain KC, Girschick HJ, Dedeoglu F, Hedrich CM, Laxer RM, Ferguson PJ, Naden R, Ozen S. EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis. Arthritis Rheumatol. 2026 Mar;78(3):537-547. doi: 10.1002/art.43137. Epub 2025 May 8. PMID: 40342207.
* Gill AS, Sharma P, Nassar M, Marte E. Hypophosphatasia: A case report. World J Clin Cases. 2025 Jul 26;13(21):103642. doi: 10.12998/wjcc.v13.i21.103642. PMID: 40726933; PMCID: PMC12068182.
* Mannes I, Rothenbuhler A, Merzoug V, Di Rocco F, Linglart A, Adamsbaum C. Imaging patterns in pediatric hypophosphatasia. Pediatr Radiol. 2022 May;52(5):998-1006. doi: 10.1007/s00247-021-05232-3. Epub 2021 Dec 2. PMID: 34854966.
* Shapiro JR, Lewiecki EM. Hypophosphatasia in Adults: Clinical Assessment and Treatment Considerations. J Bone Miner Res. 2017 Oct;32(10):1977-1980. doi: 10.1002/jbmr.3226. Epub 2017 Aug 16. PMID: 28731215.
* Bowden SA, Foster BL. Alkaline Phosphatase Replacement Therapy for Hypophosphatasia in Development and Practice. Adv Exp Med Biol. 2019;1148:279-322. doi: 10.1007/978-981-13-7709-9_13. PMID: 31482504.
* Yoshida H, Murakami T, Ogawa A, Sunouchi T, Hidaka N, Ito N, Murakami H, Kawasaki H, Akiyama T, Nakajima K, Yabe D, Yamamoto T. Adult hypophosphatasia presenting with recurrent acute joint pain. Endocrinol Diabetes Metab Case Rep. 2025 Jan 1;2025(1). doi: 10.1530/EDM-24-0121. Epub 2025 Jan 27. PMID: 39868560; PMCID: PMC11811822.
* Silva I, Castelão W, Mateus M, Branco JC. Childhood hypophosphatasia with myopathy: clinical report with recent update. Acta Reumatol Port. 2012 Jan-Mar;37(1):92-6. PMID: 22781519.
* Charles JF, Malabanan AO, Krolczyk S, Dahir KM. Rare Causes of Musculoskeletal Pain: Thinking beyond Common Rheumatologic Diseases. Case Rep Rheumatol. 2024;2024:6540026. doi: 10.1155/2024/6540026. Epub 2024 Jan 18. PMID: 38283708; PMCID: PMC10810688.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.